Event Details
                    Agenda
                                    
                
                    
                    Event Details
                    Meeting Objectives
The purpose of the Urology Program Directors' Meeting is to bring together the Directors of the Urology O'Brien Centers and their project directors, the Planning Center Directors for Interdisciplinary Research in Benign Urology, and the Directors for the Urologic Research (KURe) Career Development Program and their fellows. This meeting will promote interactions between Centers and Programs and the sharing of resources.
                
                
                    
                    Agenda
                    December 9, 2013
    - 9:00 a.m.
 
    - Introductory Remarks
    Robert Star, M.D., Tracy Rankin, Ph.D., Deborah Hoshizaki, Ph.D.—National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 
    - 9:15 a.m.
 
    - Introduction to the Large Urology Research Programs
    Robert Star, M.D., Tracy Rankin, Ph.D., Deborah Hoshizaki, Ph.D.—NIDDK 
KURe K12 Program-New Programs (10 min presentations/5 min questions)
    - 9:30 a.m.
 
    - Dale Edmond Bjorling, D.V.M. —University of Wisconsin
 
    - 9:45 a.m.
 
    - Firouz Daneshgari, M.D.—Case Western Reserve University
 
    - 10:00 a.m.
 
    - Stephen Jay Freeland, M.D.—Duke University
 
    - 10:15 a.m.
 
    - Break
 
KURe K12 Program-Continuing Programs (30 min presentations/5 min questions)
    - 10:30 a.m.
 
    - Laurence Baskin, M.D. and Peter R. Carroll—University of California San Francisco
 
    - 11:05 a.m.
 
    - Dolores Jean Lamb, Ph.D.—Baylor College of Medicine
 
    - 11:40 a.m.
 
    - Discussion of Best Practices and Possible Areas for Improvement
 
K12 Scholars—Short Talks (15 min presentation/5 min questions)
    - 12:00 p.m.
 
    - Benjamin Breyer, M.D.—University of California San Francisco
 
    - 12:20 p.m.
 
    - Abhishek Seth, M.D.—Baylor College of Medicine 
 
    - 12:40 p.m.
 
    - Nadia Roan, Ph.D.—University of California San Francisco 
 
    - 1:00 p.m.
 
    - Lunch
 
    - 1:30 p.m.
 
    - Hillary Copp, M.D.—University of California San Francisco
 
    - 1:50 p.m.
 
    - Jonathan Routh, M.D.—Duke University
 
P20 Program: Session 1
    - 2:10 p.m.
 
    - The Role of Altered Permeability in Bladder Diseases
    Robert Hurst, Ph.D.—University of Oklahoma Health Sciences Center
    (30 min presentation/10 min questions) 
    - 2:50 p.m.
 
    - Neurogenic Bladder Dysfunctions in Neurological Disorders
    Anna Malyhkina, Ph.D.—University of Pennsylvania
    (40 min presentation/10 min questions) 
    - 3:40 p.m.
 
    - Break
 
    - 3:55 p.m.
 
    - Introduction to nGUDMAP
    Michelle Southard-Smith, Ph.D.—Vanderbilt University 
    - 4:30 p.m.
 
    - GUDMAP Workshop
    Chris Armit, Ph.D.—University of Edinburgh 
    - Poster Session
 
December 10, 2013
P20 Program: Session 2 (30 min presentations/10 min questions)
    - 8:00 a.m.
 
    - Mechanism of Cytokine-Induced Lower Urinary Track Pathology
    Michael Ittmann, M.D., Ph.D.—Baylor College of Medicine 
    - 8:40 a.m.
 
    - Molecular Signatures Associated with Prostatic Inflammation in Rodent
    Zhou Wang, Ph.D.—University of Pittsburgh 
    - 9:20 a.m.
 
    - Break
 
    - 9:35 a.m.
 
    - Biology and Pathophysiology of urothelium in Bladder Disease
    Gerald Andriole, M.D.—Washington University in Saint Louis 
U54 Program
    - 10:15 a.m.
 
    - Overview
    John Lieske, M.D.—Mayo Clinic
    (15 min presentation/10 min questions) 
    - 10:40 a.m.
 
    - Non-invasive Characterization of Renal Stones
    Cynthia McCollough, Ph.D.— Mayo Clinic
    (20 min presentation/10 min questions) 
    - 11:10 a.m.
 
    - Break
 
    - 11:25 a.m.
 
    - Visualization and Pathophysiology of Renal Stone Precursor
    John Lieske, M.D.—Mayo Clinic
    (20 min presentation/10 min questions) 
    - 11:55 a.m.
 
    - Epidemiology of Kidney Stone Recurrence
    Andrew Rule, M.D.—Mayo Clinic
    (20 min presentation/10 min questions) 
    - 12:25 p.m.
 
    - Using a Drosophila Model to Identify Inhibitors of Oxalate
    Michael Romero, Ph.D.—Mayo Clinic
    (20 min presentation/10 min questions) 
    - 12:55 p.m.
 
    - Lunch
 
P20 Program: Session 3 (30 min presentation/10 min questions)
    - 1:10 p.m.
 
    - Critical Role of Metals in Calcification and Kidney Stone Formation
    Marshall Stoller, Ph.D.—Burnham Institute 
K12 Scholars—Short Talks (15 min presentation/5 min questions)
    - 1:50 p.m.
 
    - Thomas Chi, M.D.— University of California San Francisco
 
    - 2:10 p.m.
 
    - Adam Szafran, M.D., Ph.D.—Baylor College of Medicine
 
    - 2:30 p.m.
 
    - Carolina Jorgez, Ph.D.—Baylor College of Medicine
 
    - 2:50 p.m.
 
    - Nazema Siddiqui, M.D.—Duke University
 
    - 3:10 p.m.
 
    - Break
 
Plenary Address
    - 3:25 p.m.
 
    - Dorry Segev, M.D., Ph.D.—Johns Hopkins Medicine
 
December 11, 2013
K12 Scholars—Short Talks (15 min presentation/5 min questions)
    - 8:00 a.m.
 
    - Mir Reza Bekheirnia, M.D.—Baylor College of Medicine
 
    - 8:20 a.m.
 
    - Shweta Choudhry, Ph.D.—Unversity of California San Francisco
 
P20 Program: Session 4 (40 min presentations/10 min questions)
    - 8:40 a.m.
 
    - Regeneration, Repair, and Remodeling of the Lower Urinary Tract
    George Christ, Ph.D.—Wake Forest School of Medicine 
    - 9:30 a.m.
 
    - Break
 
    - 9:45 a.m.
 
    - Obesity, Inflammation, and BPH
    Simon Hayward, Ph.D.—Vanderbilt University Medical Center 
    - 10:35 a.m.
 
    - Mechanism of Age-Related Voiding Dysfunction Defined by Systems Genetics
    Mark Zeidel, M.D.—Beth Israel Deaconess Medical Center/Harvard Medical School 
    - 11:25 a.m.
 
    - Urinary Biomarkers of Lower Urinary Tract Symptoms (LUTS) in Men
    Wade Bushman 
    - 12:15 p.m.
 
    - Lunch
 
    - 1:00 p.m.
 
    - Closed Session with P20 EEP
 
    - 2:00 p.m.
 
    - Feedback Session to the P20 PIs and NIDDK
 
    - 3:00 p.m.
 
    - Adjournment